CI Investments Inc
ROIV icon

CI Investments Inc’s Roivant Sciences ROIV Stock Holding History

CI Investments Inc’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Buy
+6,081
New +$180K ﹤0.01% 734
2025
Q4 		– Sell
-602
Closed -$9K – 1131
2025
Q3 		$9K Buy
602
+18
+3% +$223 ﹤0.01% 1229
2025
Q2 		$7K Sell
584
-62
-10% -$672 ﹤0.01% 1253
2025
Q1 		$7K Sell
646
-31
-5% -$335 ﹤0.01% 1259
2024
Q4 		$8K Sell
677
-10,901
-94% -$129K ﹤0.01% 1258
2024
Q3 		$134K Buy
11,578
+222
+2% +$2.53K ﹤0.01% 769
2024
Q2 		$120K Sell
11,356
-978
-8% -$10.7K ﹤0.01% 767
2024
Q1 		$130K Buy
12,334
+4,352
+55% +$46.9K ﹤0.01% 817
2023
Q4 		$90K Buy
7,982
+7,315
+1,097% +$71.3K ﹤0.01% 856
2023
Q3 		$8K Buy
667
+90
+16% +$1.02K ﹤0.01% 1206
2023
Q2 		$6K Buy
577
+558
+2,937% +$4.99K ﹤0.01% 1241
2023
Q1 		$0 Buy
+19
New +$156 ﹤0.01% 1290

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

CI Investments Inc's ROIV Position: Q2 2026 in Review

CI Investments Inc opened a new position in Roivant Sciences (ROIV) in Q2 2026: 6,081 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #734 among its holdings. This is a return to the name: CI Investments Inc previously reported a position in ROIV as recently as Q3 2025.

CI Investments Inc first reported a position in ROIV in Q1 2023 and has held it in 12 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • CI Investments Inc held 6,081 shares of Roivant Sciences worth $215K as of Q2 2026.
  • Roivant Sciences was a new CI Investments Inc position in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of CI Investments Inc's portfolio in Q2 2026, its #734 holding.
  • CI Investments Inc first reported a position in Roivant Sciences in Q1 2023 and has held it in 12 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.